The story of CELOX™ PPH is a captivating narrative of ingenuity with life-saving implications. Its origins trace back to the triumph of CELOX™ gauze, a stalwart in trauma, emergency care and military for nearly two decades. After years of effectively employing CELOX™ gauze in these rigorous settings, a promising opportunity emerged in the realm of PPH. The journey towards the creation of CELOX™ PPH commenced with an exhaustive research and development phase where it underwent scrupulous testing and assessment over a period of 10+ years, ensuring its utmost safety and effectiveness in intrauterine applications.
The culmination of this endeavour arrived in September 2022, marked by the granting of the prestigious CE marking. This emblem of approval signified CELOX™ PPH’s unwavering adherence to stringent European standards for safety and efficacy. This achievement marked a significant milestone, as it enabled CELOX™ PPH to be accessible to healthcare professionals across the European Economic Area (EEA).
Each year, approximately 14 million women endure PPH, leading to roughly 80,000 maternal deaths worldwide. PPH stands as one of the foremost contributors to maternal mortality globally. Even for those fortunate enough to survive, it can result in enduring health challenges, such as reproductive health disabilities. This stark reality underscores the urgent need for effective remedies. CELOX™ PPH emerges as a groundbreaking solution with the potential to safeguard the lives of countless women worldwide.
This evolution from military use to the delivery room serves as a testament to CELOX™ technology’s versatility and adaptability and its unwavering commitment to saving lives, regardless of the setting. It stands as a prime example of how advancements developed in one arena can be harnessed to make a transformative difference in another, ultimately benefiting individuals and communities around the world.
Today, CELOX™ PPH has established numerous distribution partnerships throughout the EEA and other countries around the world. This expansion not only extends its influence but also cements its position as a pivotal player in revolutionising maternal healthcare on a global scale.